For Immediate Release
Medical Marijuana Patients Applaud House Reauthorization Of Rohrabacher-Farr CJS Amendment
House Vote Would Continue Prohibition on Federal Interference in State-Level Medical Marijuana Programs in 39 States
WASHINGTON - The United States House of Representatives voted to reauthorize the Rohrabacher-Farr medical cannabis (marijuana) amendment to the Commerce, Science, and Justice (CJS) Appropriations bill for fiscal year 2015 by a margin of 242 to 186. The Rohrabacher-Farr medical cannabis amendment bans the Department of Justice from spending money to prevent the implementation of state-level medical cannabis programs, removing funding for federal medical cannabis raids, arrests and prosecutions in states where medical cannabis is legal. With the addition of seven states in the last year the Rohrabacher-Farr medical cannabis amendment now covers 39 states and protects access to medical cannabis programs for 275 million citizens in those states.
“The Rohrabacher-Farr medical cannabis amendment offers crucial protection for medical cannabis patients and the people that provide them with access to much needed medicine,” said Steph Sherer Americans for Safe Access Executive Director. “Having reaffirmed the federal government’s commitment to not interfere with state medical cannabis programs it’s now time to move forward and create a framework for federal and state cooperation in medical cannabis by passing the CARERS Act."
We Interrupt This Article with an Urgent Message!
Common Dreams is a not-for-profit organization. We fund our news team by pooling together many small contributions from our readers. No advertising. No selling our readers’ information. No reliance on big donations from the 1%. This allows us to maintain the editorial independence that our readers rely on. But this media model only works if enough readers pitch in.
SCROLL TO CONTINUE WITH CONTENT
Never Miss a Beat.
Get our best delivered to your inbox.
Last year the House of Representatives passed the Rohrabacher-Farr medical cannabis amendment by a margin of 219-189 with a strong bipartisan show of support. Lead by the support of Senator Barbara Mikulski (D-MD) the Rohrabacher-Farr medical cannabis amendment remained in the CRomnibus bill that President Obama signed into law. Its passage marked the first time Congress approved a medical cannabis reform since designating cannabis in Schedule I of the Controlled Substances Act. Today approximately 2.4 million Americans currently utilize medical cannabis programs.
“With the recent addition of Texas the vast majority of the country is now living in a state with at least some legal use of medical cannabis,” said Mike Liszewski Americans for Safe Access Government Affairs Director. “This vote shows the growing recognition that the only responsible course of action is for the federal government to leave state medical cannabis programs alone and let them provide their citizens with this much needed medical option.”
The Rohrabacher-Farr medical cannabis amendment was co-sponsored by a bipartisan coalition of six Republicans and six Democratic members including Dana Rohrabacher (R-CA), Sam Farr (D-CA), Reid Ribble (R-WI), Barbara Lee (D-CA), Thomas Massie (R-KY), Earl Blumenauer (D-OR), Joe Heck (R-NV), Steve Cohen (D-TN), Don Young (R-AK) Jared Polis (D-CO), Tom McClintock (R-CA), Dina Titus (D-NV).
This is the world we live in. This is the world we cover.
Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.
Please select a donation method:
Americans for Safe Access is the nation's largest organization of patients, medical professionals, scientists and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research.